TARGET IMMUNOTHERAPY IN SECONDARY IMMUNE DEFICIENCY WITH INFECTIOUS SYNDROME
- Authors: Nesterova I.V.1,2
-
Affiliations:
- Federal State Budget Educational Institution of Higher Education «Kuban State Medical University» of the Ministry of Health Development of Russia
- Federal State Autonomous Budget Educational Institution of Higher Professional Education «Peoples’ Friendship University of Russia» of Ministry of Education and Science of Russia
- Issue: Vol 22, No 4 (2019)
- Pages: 1512-1516
- Section: ORIGINAL ARTICLES
- URL: https://journal-vniispk.ru/1028-7221/article/view/119650
- DOI: https://doi.org/10.31857/S102872210007074-6
- ID: 119650
Cite item
Full Text
Abstract
About the authors
I. V. Nesterova
Federal State Budget Educational Institution of Higher Education «Kuban State Medical University» of the Ministry of Health Development of Russia;Federal State Autonomous Budget Educational Institution of Higher Professional Education «Peoples’ Friendship University of Russia» of Ministry of Education and Science of Russia
Author for correspondence.
Email: fake@neicon.ru
Chief Researcher of Central Research Laboratory, Krasnodar;
Doctor of Medical Sciences (MD), Professor, Professor of the Department of Allergology and Immunology, Moscow
Russian FederationReferences
- Нестерова И. В. Вторичные иммунодефициты и методы их коррекции в практике врачаоториноларинголога. «Иммунотерапия в практике ЛОР-врача и терапевта», под редакцией А. С. Симбирцева, Г. В. Лавреновой. Спб.: Диалог, 2018, 32–97.
- Нестерова И. В. Иммунотропные препараты и современная иммунотерапия в клинической иммунологии и медицине. Аллергология и иммунология, 2000, 23(3), 18–28.
- Tanaka T., Narazaki M., Kishimoto T. Immunotherapeutic implications of IL-6 blockade for cytokine storm. Immunotherapy, 2016, 8(8), 959–970.
- Van Ton A. M. P., Kox M., Abdo W. F., Pickkers P. Precision Immunotherapy for Sepsis. Frontiers In Immunology, 2018, https://doi.org/10.3389/fimmu.2018. 01926)).
- Castro M. G., Baker G. J., Lowenstein P. R. Blocking immunosuppressive checkpoints for glioma therapy: the more the merrier!. Clin Cancer Res., 2014, 20(20), 5147–5149.
- Kirkham B. W., Kavanaugh A., Reich K. Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis. Immunology, 2014, 141(2), 133–142. 7. Ballow M., Fleisher T. Secondary immunodeficiency induced by drugs and biologic therapies. UpToDate, 2015.https://www.uptodate.com/contents/secondaryimmunodeficiency-induced-by-biologic-therapies.
Supplementary files
